Many patients with psoriatic disease go underdiagnosed and undertreated, potentially leading to debilitating emotional and physical ramifications. Don’t let your patients be part of this group. Get the knowledge you need to accurately identify all forms of psoriatic disease and properly treat patients with newer—and potentially more effective—therapies. This brief expert-led session arms you with guideline recommendations and key insights to help you confidently manage this progressive illness through all its forms and phases. Importantly, you’ll learn when a referral is appropriate in your patient with psoriatic disease.

Through fifteen quick-hitting cases, this session will review select dermatologic rashes and neoplasms, both benign and malignant, that are commonly encountered by primary care physicians. Clinical descriptions of acne, alopecia areata, atopic dermatitis/eczema, lichen planus, pityriasis rosea, psoriasis, rosacea, seborrheic dermatitis, stasis dermatitis, tinea cruris/corporis/unguium, acrochordon, cherry angioma, seborrheic keratosis, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, and melanoma are provided, followed by suggestions for treatment and management within the scope of primary care. Recommendations as to when to refer patients to Dermatology are noted. Reference atlas, textbook, website, and mobile application recommendations are also provided.

What do primary care providers need to know about rashes and eye complaints in the acute care setting? Join expert faculty as they review important questions they get asked about these topics!

There have been many advances in the management of dermatologic disease. This session will provide an update on common skin disorders including acne diagnosis and management, atopic dermatitis, psoriasis, scabies, and neoplasms.

What do primary care providers need to know about HIV and Acne/Rosacea? Join expert faculty as they review important questions they get asked about these topics!

One in five Americans will develop skin cancer by the age of 70. This session will provide an overview of the major types of skin cancers and precancers, as well as provide guidance in distinguishing these from common benign tumors. This session will also equip the primary care provider with information regarding treatment and prevention of both benign and malignant skin tumors.

Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk of using these agents is extremely small.